Trials / Unknown
UnknownNCT04152707
Clinical Evaluation of Splendor X for Hair Removal
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 44 (estimated)
- Sponsor
- Lumenis Be Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
At least 40 healthy male or female subjects that wish to remove their hair will be enrolled to this study. Each subject will receive five treatments at 6-8 weeks intervals. Subjects will return for follow-up visits at 3, 6, 9, and 12 months after the last treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Splendor X | The Splendor X has two wavelengths in one system: Nd:YAG (1064nm) and Alexandrite (755nm). |
Timeline
- Start date
- 2020-01-08
- Primary completion
- 2023-03-01
- Completion
- 2023-04-01
- First posted
- 2019-11-05
- Last updated
- 2021-07-02
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04152707. Inclusion in this directory is not an endorsement.